Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation HAYES, Inc.. Scrambler/Calmare Pain Therapy (Calmare Therapeutics Inc.) for the management of chronic pain related to cancer or cancer treatment. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2016 Authors' conclusions Description of Technology: Scrambler Therapy (ST) (also referred to as Calmare Pain Therapy and transcutaneous electrical modulation pain reprocessing; Calmare Therapeutics Inc.) is a noninvasive, transdermal treatment for the symptomatic relief of chronic pain. Treatment is performed by applying electrodes corresponding to the dermatome on the skin just above and below the area of pain. The system is a multiprocessor with artificial neurons that generate synthetic action potentials. Algorithms take into account previous outputs and frequency, duration, and amplitude of modulation, and are used to assemble these signals to deliver patient-specific electrostimulation. The manufacturer suggests that the resultant artificial no-pain signals created by the electrostimulator block real-pain signals. The postulated mechanism for prolonged pain relief is a resetting of calcium channels or remodulation of the pain response.
Patient Population: The ST device is indicated for use in the symptomatic relief of chronic, intractable pain, postsurgical and posttraumatic acute pain, symptomatic relief of acute pain, and symptomatic relief of postoperative pain. The Food and Drug Administration does not specify its use for cancer patients. Indexing Status Subject indexing assigned by CRD MeSH Chronic Pain; Humans; Neoplasms; Pain Management Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32016000964 Date abstract record published 30/08/2016 |